BACKGROUND: The most practical measure to augment the available number of liver grafts and thus reduce waiting list mortality is to increase the donor age limit. We hypothesized that with careful selection of old liver donors without age limit it should be possible to obtain good patient and graft survival. METHODS: The present study comprises 351 adults who underwent liver transplantation. They were divided into three groups according to the age of the liver donors: group 1: 226 recipients of donors <60 years; group 2: 75 recipients of donors between 60 and 70 years; and group 3: 50 recipients of donors >70 years. A comparative study among the groups was performed. RESULTS: Patient survival rates at 1, 3, and 5 years were, respectively, 81.0, 76.1, and 71.1 % in group 1; 83.8, 74, and 72.2 % in group 2; and 76, 70.0, and 62.9 % in group 3 (P = NS). Graft survival at 1, 3, and 5 years was, respectively, 74.8, 69.0, and 64.1 % in group 1; 82.7, 71.4, and 69.6 % in group 2; and 71.4, 64.8, and 58.3 % in group 3 (P = NS). We analyzed the use of older grafts in recipients with HCV cirrhosis and did not find significant differences in patient and graft survival at 1, 3, and 5 years. In multivariate analysis increased donor body mass index and decreased recipient albumin were associated with lower patient and graft survival. CONCLUSIONS: Because patient and graft survival rates are not affected by donor age, well-selected older donor livers can be safely used if they show good function and preharvesting conditions.
BACKGROUND: The most practical measure to augment the available number of liver grafts and thus reduce waiting list mortality is to increase the donor age limit. We hypothesized that with careful selection of old liver donors without age limit it should be possible to obtain good patient and graft survival. METHODS: The present study comprises 351 adults who underwent liver transplantation. They were divided into three groups according to the age of the liver donors: group 1: 226 recipients of donors <60 years; group 2: 75 recipients of donors between 60 and 70 years; and group 3: 50 recipients of donors >70 years. A comparative study among the groups was performed. RESULTS:Patient survival rates at 1, 3, and 5 years were, respectively, 81.0, 76.1, and 71.1 % in group 1; 83.8, 74, and 72.2 % in group 2; and 76, 70.0, and 62.9 % in group 3 (P = NS). Graft survival at 1, 3, and 5 years was, respectively, 74.8, 69.0, and 64.1 % in group 1; 82.7, 71.4, and 69.6 % in group 2; and 71.4, 64.8, and 58.3 % in group 3 (P = NS). We analyzed the use of older grafts in recipients with HCV cirrhosis and did not find significant differences in patient and graft survival at 1, 3, and 5 years. In multivariate analysis increased donor body mass index and decreased recipient albumin were associated with lower patient and graft survival. CONCLUSIONS: Because patient and graft survival rates are not affected by donor age, well-selected older donor livers can be safely used if they show good function and preharvesting conditions.
Authors: I R Marino; H R Doyle; C Doria; L Aldrighetti; T Gayowski; C Scotti-Foglieni; H Furukawa; J J Fung; A G Tzakis; T E Starzl Journal: Transplant Proc Date: 1995-02 Impact factor: 1.066
Authors: J L Bernat; A M D'Alessandro; F K Port; T P Bleck; S O Heard; J Medina; S H Rosenbaum; M A Devita; R S Gaston; R M Merion; M L Barr; W H Marks; H Nathan; K O'connor; D L Rudow; A B Leichtman; P Schwab; N L Ascher; R A Metzger; V Mc Bride; W Graham; D Wagner; J Warren; F L Delmonico Journal: Am J Transplant Date: 2006-02 Impact factor: 8.086
Authors: M E Rinella; E Alonso; S Rao; P Whitington; J Fryer; M Abecassis; R Superina; S L Flamm; A T Blei Journal: Liver Transpl Date: 2001-05 Impact factor: 5.799
Authors: Mark W Russo; Joseph A Galanko; Steven L Zacks; Kimberly L Beavers; Michael W Fried; Roshan Shrestha Journal: Am J Transplant Date: 2004-07 Impact factor: 8.086
Authors: Victor I Machicao; Hugo Bonatti; Murli Krishna; Bashar A Aqel; Frank J Lukens; Justin H Nguyen; Barry G Rosser; Raj Satyanarayana; Hani P Grewal; Winston R Hewitt; Denise M Harnois; Julia E Crook; Jeffery L Steers; Rolland C Dickson Journal: Transplantation Date: 2004-01-15 Impact factor: 4.939
Authors: R J Ploeg; A M D'Alessandro; S J Knechtle; M D Stegall; J D Pirsch; R M Hoffmann; T Sasaki; H W Sollinger; F O Belzer; M Kalayoglu Journal: Transplantation Date: 1993-04 Impact factor: 4.939
Authors: Speranta Iacob; Vito R Cicinnati; Philip Hilgard; Razvan A Iacob; Liana S Gheorghe; Irinel Popescu; Andrea Frilling; Massimo Malago; Guido Gerken; Christoph E Broelsch; Susanne Beckebaum Journal: Transplantation Date: 2007-07-15 Impact factor: 4.939
Authors: Carlos Jiménez-Romero; Felix Cambra; Oscar Caso; Alejandro Manrique; Jorge Calvo; Alejandro Marcacuzco; Paula Rioja; David Lora; Iago Justo Journal: World J Gastroenterol Date: 2017-05-07 Impact factor: 5.742
Authors: Jacob D de Boer; Joris J Blok; Hein Putter; Jacob J E Koopman; Bart van Hoek; Undine Samuel; Marieke van Rosmalen; Herold J Metselaar; Ian P J Alwayn; Markus Guba; Andries E Braat Journal: Liver Transpl Date: 2019-02 Impact factor: 5.799